Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06605469 · ClinicalTrials.gov registry record
Ejaculatory and Orgasmic Dysfunction Registry
A clinical trial of Ejaculatory Dysfunction and Premature Ejaculation, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06605469: Recruiting study of Ejaculatory Dysfunction and Premature Ejaculation, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.
NCT06605469 is a study of Ejaculatory Dysfunction and Premature Ejaculation that is actively recruiting participants, run by Charitable Union for the Research and Education of Peyronie's Disease. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06605469, a study of Ejaculatory Dysfunction and Premature Ejaculation, is actively recruiting participants, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory and/or orgasmic dysfunctions in men. The objective is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic dysfunction. Participants will submit questionnaires about their diagnosis and treatment efficacy and multiple time intervals.
Primary Outcome
Report subjective efficacy of therapies used to treat ejaculatory dysfunction. Study participants will have the option of indicating if they had used any treatments to treat ejaculatory disorders. If so, they will then be asked to measure its efficacy at improving their symptoms using a 1-10 scale (10 being very effective).
Conditions Studied
Study Locations (1)
Utah
- The Male Fertility and Peyronie's Clinic - Orem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2029-05-31 |
What NCT06605469 shows while recruiting
NCT06605469 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 7 conditions, with Ejaculatory Dysfunction appearing as the primary indexed condition, and to 0 interventions.
NCT06605469 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06605469 about?
NCT06605469 is a clinical study titled "Ejaculatory and Orgasmic Dysfunction Registry". The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory and/or orgasmic dysfunctions in men. The objective is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic...
What is the current status of trial NCT06605469?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-05-30. Estimated completion is 2029-05-31.
What conditions does trial NCT06605469 study?
This clinical trial studies the following conditions: Ejaculatory Dysfunction, Premature Ejaculation, Delayed Ejaculation, Anorgasmia, Anejaculation.
Who is sponsoring clinical trial NCT06605469?
This trial is sponsored by Charitable Union for the Research and Education of Peyronie's Disease, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06605469 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ejaculatory Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI